Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering.
Launched by SAINT-JOSEPH UNIVERSITY · Apr 28, 2021
Trial Information
Current as of May 20, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age between 18 and 65 years
- • scheduled for a surgery under spinal anesthesia
- Exclusion Criteria:
- • pregnant or breastfeeding (for the women), if they are
- • Allergy to any of the drugs to be used
- • Long QT syndrome
- • Hepatic insufficiency
- • Renal failure
- • Parkinson's disease
- • Epilepsy
- • Glaucoma
- • Phenylketonuria
About Saint Joseph University
Saint-Joseph University (USJ) is a prestigious academic institution located in Beirut, Lebanon, renowned for its commitment to excellence in education and research. With a strong emphasis on interdisciplinary collaboration, USJ actively engages in clinical trials aimed at advancing medical knowledge and improving patient care. The university's research initiatives are supported by a team of experienced professionals, state-of-the-art facilities, and a robust network of partnerships with local and international health organizations. USJ is dedicated to ethical practices and the highest standards of scientific rigor, ensuring that its clinical trials contribute meaningfully to the healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beirut, , Lebanon
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials